Treatment-Refractory Cancers
1 clinical trials · Condition
◉ Watch Treatment-Refractory Cancers
| Record | Firm | Date |
|---|---|---|
| Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers (NCT03388632) | National Cancer Institute (NCI) | 2018-02-05 |
Track Treatment-Refractory Cancers automatically
Every clearance here is in the API, with alerts when new ones post.